Fourteen months, in order, with the documents attached.
This is not an argument. It is a timeline. Every entry is drawn from a filing the company made, a filing made about the company, or a court filing — and every entry links to the source. Where an entry comes from a complaint or a press release rather than a disclosure, it says so.
Entries run through 19 November 2026. This chronology was last verified on 20 November 2026. Anything filed after that date is not reflected here — the company's EDGAR filing list is always the current version of the record.
The last four entries are scheduled dates rather than reported events. Some earlier entries rest on the complaint or on an announcement and say so in the text without linking the document; everything else links straight to the filing.
The steps below this point — the December meetings and the consent window — have already happened. Nothing here predicts the outcome: the Chancery case, any Nasdaq hearings panel decision and any further solicitation are all later developments, and the filings are where you find them.
-
Scilex agrees to buy 278,914,094 shares for $150 million in Bitcoin.
15,000,000 shares outright plus a pre-funded warrant for a further 263,914,094, at a spot rate of $112,915.52 per Bitcoin — about 1,328.43 BTC. The transaction creates the digital-asset position that later becomes the centre of the restatement.
Form 8-K, Oct 26, 2026, Item 4.02, “Background and Nature of Error”.
-
A $25.03 million convertible note and a voting agreement with Streeterville Capital.
The note is issued under a securities purchase agreement, together with a voting agreement — the arrangement that later drives the share-issuance proposal at the annual meeting.
-
Wendy Wilson resigns; Jeffrey Tirman is appointed to the board.
Disclosed in an 8-K. Tirman is later one of the eight directors named for removal.
-
The Streeterville note is amended to set a $0.0632 floor price.
A floor price — calculated as 20% of the Nasdaq minimum price at issuance — becomes relevant to how a reverse split interacts with conversion terms.
-
The Audit Committee concludes four periods can no longer be relied upon.
Four months after the company found it could not complete a withdrawal of Bitcoin from its wallet at Biconomy, the committee makes the determination that triggers the restatement.
Form 8-K, Oct 26, 2026, which dates the determination to October 20.
-
The restatement is disclosed. Total assets are expected to fall by $8.1m to $92.2m, depending on the period.
A Form 8-K under Item 4.02 discloses the committee's determination across four periods — September 2025 to June 2026 — and a going-concern reassessment. The expected reduction in total assets is $8.1m at September 30, 2025, $92.2m at December 31, 2025, $57.1m at March 31, 2026 and $49.0m at June 30, 2026. The filing is signed by Brett Moyer as chief financial officer.
Form 8-K, Oct 26, 2026. The 1,029,489,970 share count is not stated in this filing — it comes from the proxy filed four days later, which gives it as of October 26.
-
Bradley asks the board to consider removing Moyer as CFO.
Per the verified complaint. Two days later, Bradley is suspended.
-
A $90–100 million non-dilutive facility is delivered to management.
Alleged in the verified complaint, which claims the term sheet was withheld from independent directors. The amended complaint of November 13, 2026 also quotes the draft minutes of the November 1 meeting recording that no term sheet or proof of funds was presented there. The company disputes the allegation.
-
Bradley is suspended — and a diluted proxy is filed the same day.
The complaint alleges Moyer suspended Bradley unilaterally, without a board vote and without authority under the bylaws. On the same day the company files a preliminary proxy for a December 16 annual meeting: nine directors, ratification of CBIZ, a reverse split of 1-for-2 to 1-for-50, and approval of share issuances under the Streeterville note above the Nasdaq 5635(d) limit.
-
A creditor issues an acceleration default notice.
Per the verified complaint, under a note held by EOS Technology Holdings.
-
The board removes Bradley as CEO and President. He stays a director.
Approved by every director other than Bradley, who voted against. The company's Form 8-K confirms both the removal and that he continues to serve on the board.
-
A divided board vote, after minutes circulated about an hour before.
Per the verified complaint, which alleges outside counsel circulated multi-page draft minutes shortly before the meeting and that independent directors broke ranks.
-
The board is told the executive team will not be paid for the pay period.
Per the verified complaint.
-
Moyer is named CEO and President. Bradley sues in Chancery.
The board appoints Moyer CEO and President, Kimberly Briskey Chair, Sriram Peruvemba Vice Chair, Teresa Gallo COO, Stanley Mbugua CFO and Christopher Hardt Audit Committee Chair. The same day, Bradley files Bradley v. Tirman et al., C.A. No. 2026-1478, a verified complaint under DGCL §§ 225 and 111, seeking a declaration that the removal is void, reinstatement, a status-quo order and an expedited trial.
Form 8-K, Nov 9, 2026 · Verified complaint, Nov 6 · Amended complaint, Nov 13 · Chancery docket · CourtConnect, the court's own search
-
The verified amended complaint is filed: fraud, fiduciary duty and derivative claims.
A verified amended and supplemental complaint is filed in C.A. No. 2026-1478. It keeps the § 225 and § 111 counts and adds five: fraud and fraudulent concealment; equitable fraud and negligent misrepresentation, pleaded in the alternative; constructive fraud; breach of the duty of loyalty, including good faith and candor; and civil conspiracy and aiding and abetting. The new counts are pleaded derivatively on the company's behalf — Count VIII individually and, in the alternative, derivatively — so damages on them would be paid to Datavault, not to Bradley, and they turn on the NYIAX merger and the Abri guarantee rather than on the removal. The relief sought now includes a declaration that Bradley is Chief Executive Officer and President, a declaration that the November 6 appointments are invalid, and a status quo order restraining extraordinary debt restructuring, material financing agreements and convertible-note waivers without court approval or the parties' agreement.
Verified amended complaint, Nov 13, 2026, Counts IV–VIII and Prayer for Relief A–E. Allegations, not findings; the company disputes them. The original complaint of November 6 is here.
-
Nasdaq suspends trading. Bradley signs a written consent.
Nasdaq suspends DVLT effective November 17 under the $1.00 minimum bid price rule and the low-price rule, which requires suspension after ten consecutive business days below $0.10. The company says it will request a hearing before the Nasdaq Hearings Panel. Separately, Bradley executes a written consent under DGCL § 228 and emails it to the board at 4:58 p.m. ET.
Form 8-K, Nov 13, 2026, Items 3.01 and 8.01 — Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A)(iii).
-
The consent is delivered by hand in Wilmington. The 60-day clock starts.
Delivered to the registered office c/o the registered agent, with a transmittal letter stating it is delivery for all purposes under § 228, including fixing the record date. This is the date that starts the consent window. It is also the record date for the December 29 special meeting — 1,030,676,667 shares outstanding.
-
DVLT begins trading on OTC Markets. The consent campaign becomes public.
A Schedule 13D/A discloses the consent solicitation: five proposals to repeal board-adopted bylaws, reserve vacancies for stockholders, remove eight directors, fix the board at eight and elect eight nominees. Bradley, his spouse and EOS report 30,147,542 shares, about 2.9%.
-
A new special meeting is noticed — and the requested ratio grows tenfold.
A fresh preliminary proxy notices a December 29, 2026 special meeting at the Philadelphia offices with a single proposal: a reverse split at any ratio from 1-for-2 to 1-for-500, in the board's sole discretion. The annual-meeting proxy filed twenty days earlier had asked for up to 1-for-50. The board's stated reason for the wider range is that the closing bid price had fallen below $0.10.
-
Proxy materials go out.
On or about this date — the mailing follows the record date, and the exact day is set by the company and its tabulator, so your broker's notice is what tells you it has happened. Street-name holders receive voting instruction forms from their brokers; holders of record receive a proxy card with an 11-digit control number.
-
The last moment your vote can be received.
Internet and telephone votes must be in by this time. Broker cut-offs are typically two to five business days earlier. Vote here →
-
Special Meeting of Stockholders, Philadelphia.
One Commerce Square, 2005 Market Street, Suite 2400. Quorum is one-third of outstanding shares. Photo ID required to attend.
-
The consent window closes.
Sixty days after the first delivery — 15 January 2027 on this site's reading, if 16 November was that first delivery. After that date, consents are counted or not — and a consent that misses the window is simply a signed piece of paper. What to do →
What the board says in its own defence.
A record that leaves out the other side is propaganda, and it is easy to dismiss. This is the board's stated case, from the same filings.
The split is a listing tool, not a dilution plan.
The proxy states the primary purpose is to raise the per-share price above $1.00 to regain compliance with the minimum bid price requirement and support the company's request to reinitiate trading and restore its Nasdaq listing. The board says it needs the wide 1-for-500 ceiling because the closing bid has been below $0.10, and that it reserves the right to abandon the split entirely.
The removal was a governance decision.
The board removed Bradley by a vote of every director other than Bradley, and its Chair said publicly that the board was moving to tighten governance and accountability and to focus resources where the clearest path to stockholder value lies. The company disputes the characterisation of events in the complaint, and no court has ruled on it.
In its own risk factors, the company says the split may not raise the price in proportion, may reduce liquidity, may increase odd-lot holdings, may reduce aggregate market capitalisation, and "will increase the proportion of authorized but unissued shares … which may dilute existing stockholders and could have anti-takeover effects." The board also says it is not proposing the split in response to any known effort to obtain control. Both halves of that sentence are worth reading before you vote.
Check the record yourself. It takes less time than reading this page.
Every company filing is free on EDGAR. If anything on this site is wrong, the primary document is right — and you should trust it over us.
Form PRE 14A — Nov 19, 2026
The December 29 special meeting. One proposal: 1-for-2 to 1-for-500.
Open →Form PRE 14A — Oct 30, 2026
The December 16 annual meeting: nine directors, CBIZ ratification, 1-for-2 to 1-for-50, Streeterville issuance.
Open →Schedule 13D/A — Nov 17, 2026
The written consent, the five proposals, the eight nominees and the 60-day window.
Open →Form 8-K — Nov 5, 2026
The termination of the CEO and President, and the fact he remains a director.
Open →Form 8-K — Nov 9, 2026
The appointment of Moyer as CEO and President, and the rest of the new officer slate.
Open →Now do something with it.
Four actions, in order of deadline. None of them require a lawyer.